Cargando…

Zoledronic Acid for prevention of bone and muscle loss after BAriatric Surgery (ZABAS)-a study protocol for a randomized controlled trial

BACKGROUND: Bariatric surgery has adverse effects on the muscular-skeletal system with loss of bone mass and muscle mass and an increase in the risk of fracture. Zoledronic acid is widely used in osteoporosis and prevents bone loss and fracture. Bisphosphonates may also have positive effects on skel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gam, Søren, Gram, Bibi, Juhl, Claus Bogh, Hermann, Anne Pernille, Hansen, Stinus Gadegaard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548152/ https://www.ncbi.nlm.nih.gov/pubmed/36209245 http://dx.doi.org/10.1186/s13063-022-06766-z

Ejemplares similares

Are Nonalcoholic Fatty Liver Disease and Bone Mineral Density Associated? — A Cross‐Sectional Study Using Liver Biopsy and Dual‐Energy X‐Ray Absorptiometry
por: Hansen, Stinus Gadegaard, et al.
Publicado: (2023)

Zoledronic acid for prevention of bone loss in patients receiving bariatric surgery
por: Liu, Yi, et al.
Publicado: (2021)

A 9,000 Year History of Seal Hunting on Lake Baikal, Siberia: The Zooarchaeology of Sagan-Zaba II
por: Nomokonova, Tatiana, et al.
Publicado: (2015)

Normal bone mineral density and bone microarchitecture in adult males with high and low risk of exercise addiction
por: Hansen, Stinus Gadegaard, et al.
Publicado: (2022)

Continuous decline in bone mineral density and deterioration of bone microarchitecture 7 years after Roux-en-Y gastric bypass surgery
por: Hansen, Stinus, et al.
Publicado: (2020)

Effect of bariatric surgery on employment status—a 7 years controlled nationwide registry study
por: Juhl, Claus Bogh, et al.
Publicado: (2021)

Physical activity monitors to enhance the daily amount of physical activity in elderly—a protocol for a systematic review and meta-analysis
por: Larsen, Rasmus Tolstrup, et al.
Publicado: (2018)

Feedback from physical activity monitors to enhance amount of physical activity in adults—a protocol for a systematic review and meta-analysis
por: Larsen, Rasmus Tolstrup, et al.
Publicado: (2019)

The Role of Body Weight on Bone in Anorexia Nervosa: A HR-pQCT Study
por: Frølich, Jacob, et al.
Publicado: (2017)

Prevalence of multimorbid degenerative lumbar spinal stenosis with knee and/or hip osteoarthritis: protocol for a systematic review and meta-analysis
por: Young, James J., et al.
Publicado: (2020)

Insufficient Mitigation of Bone Loss by Zoledronic Acid after Treatment with Denosumab
por: Park, Jung-Wee
Publicado: (2021)

Effect of Acetazolamide and Zoledronate on Simulated High Altitude-Induced Bone Loss
por: Brent, Mikkel Bo, et al.
Publicado: (2022)

The IBD-FITT study — moderate-intensity exercise for patients with inflammatory bowel disease with moderate disease activity: an open-label randomized controlled trial
por: Lund, Ken, et al.
Publicado: (2023)

The effect of zoledronate during bone healing
por: Matos, Marcos Almeida, et al.
Publicado: (2010)

The impact of a bariatric rehabilitation service on weight loss and psychological adjustment - study protocol
por: Hollywood, Amelia, et al.
Publicado: (2012)

Zoledronic acid protects from local and systemic bone loss in TNF-mediated arthritis
por: Zwerina, J, et al.
Publicado: (2004)

Zoledronic Acid after Treatment with Denosumab is Associated with Bone Loss within 1 Year
por: Kadaru, Tarun, et al.
Publicado: (2021)

The MIPAM trial: a 12-week intervention with motivational interviewing and physical activity monitoring to enhance the daily amount of physical activity in community-dwelling older adults – a study protocol for a randomized controlled trial
por: Larsen, Rasmus Tolstrup, et al.
Publicado: (2020)

Bone Response to Weight Loss Following Bariatric Surgery
por: Mele, Chiara, et al.
Publicado: (2022)

The combined effect of Parathyroid hormone (1-34) and whole-body Vibration exercise in the treatment of OSteoporosis (PaVOS)- study protocol for a randomized controlled trial
por: Jepsen, Ditte Beck, et al.
Publicado: (2018)

OR13-02 Treatment with Zoledronic Acid Subsequent to Denosumab Cannot Fully Prevent Bone Loss
por: Sølling, Anne Sophie K, et al.
Publicado: (2020)

Zoledronic acid in the management of metastatic bone disease
por: Polascik, Thomas J, et al.
Publicado: (2008)

Cryoablation combined with zoledronic acid in comparison with cryoablation and zoledronic acid alone in the treatment of painful bone metastases
por: LI, FENQIANG, et al.
Publicado: (2014)

A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis
por: Le Goff, Benoit, et al.
Publicado: (2009)

Protocol for a randomised control trial of bisphosphonate (zoledronic acid) treatment in childhood femoral head avascular necrosis due to Perthes disease
por: Jamil, Kamal, et al.
Publicado: (2017)

Zoledronic acid protects from local and systemic bone loss in tumor necrosis factor-mediated arthritis
por: Redlich, K, et al.
Publicado: (2004)

Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study
por: Tutaworn, Teerapat, et al.
Publicado: (2023)

The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design
por: Agesen, Rikke Mette, et al.
Publicado: (2019)

Effect of physical therapy on breast cancer related lymphedema: protocol for a multicenter, randomized, single-blind, equivalence trial
por: Tambour, Mette, et al.
Publicado: (2014)

Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone
por: Giveon, Sharon, et al.
Publicado: (2023)

Psychometric Validation of the BODY-Q in Danish Patients Undergoing Weight Loss and Body Contouring Surgery
por: Poulsen, Lotte, et al.
Publicado: (2017)

Topical zoledronic acid decreases micromotion induced bone resorption in a sheep arthroplasty model
por: Jakobsen, Thomas, et al.
Publicado: (2017)

Bone Loss after Allogeneic Haematopoietic Stem Cell Transplantation: A Pilot Study on the Use of Zoledronic Acid
por: Hausmann, Andreas, et al.
Publicado: (2012)

Study on Zoledronic Acid Reducing Acute Bone Loss and Fracture Rates in Elderly Postoperative Patients with Intertrochanteric Fractures
por: Liu, Zhong, et al.
Publicado: (2019)

Respiratory Effects of Treatment with a Glucagon-Like Peptide-1 Receptor Agonist in Patients Suffering from Obesity and Chronic Obstructive Pulmonary Disease
por: Altintas Dogan, Ayse Dudu, et al.
Publicado: (2022)

Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol
por: Sumi, Eriko, et al.
Publicado: (2014)

Counteracting Age-related Loss of Skeletal Muscle Mass: a clinical and ethnological trial on the role of protein supplementation and training load (CALM Intervention Study): study protocol for a randomized controlled trial
por: Bechshøft, Rasmus Leidesdorff, et al.
Publicado: (2016)

Health inequity in access to bariatric surgery: a protocol for a systematic review
por: Jackson, Timothy D, et al.
Publicado: (2014)

An intrapleural administration of zoledronic acid for inoperable malignant mesothelioma patients: a phase I clinical study protocol
por: Tada, Yuji, et al.
Publicado: (2016)

Safe Medication in Nursing Home Residents Through the Development and Evaluation of an Intervention (SAME): Protocol for a Fully Integrated Mixed Methods Study With a Cocreative Approach
por: Juhl, Marie Haase, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nc7s3i8j83ecpj80an6p2drn4s